Agent for prevention or amelioration of obesity

Abstract

To provide a pharmaceutical product or food which has an excellent fat-accumulation-inhibiting activity and/or fat-metabolism-improving activity and which is effective for inhibition or improvement of obesity, fatty liver, etc. The present invention provides an agent for preventing or ameliorating obesity containing, as an active ingredient, cells of a lactic acid bacterium belonging to the genus Pediococcus , a cell culture thereof, or an extract of any of these.

1 . An agent for preventing or ameliorating obesity containing, as an active ingredient, cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these. 
     
     
         2 . A fat-accumulation-inhibiting agent containing, as an active ingredient, cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these. 
     
     
         3 . A fat-metabolism-improving agent containing, as an active ingredient, cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these. 
     
     
         4 . A food for preventing or ameliorating obesity containing cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these. 
     
     
         5 . The agent for preventing or ameliorating obesity according to  claim 1 , the fat-accumulation-inhibiting agent according to  claim 2 , the fat-metabolism-improving agent according to  claim 3 , or the food according to  claim 4 , wherein the lactic acid bacterium belonging to the genus  Pediococcus  is  Pediococcus pentosaceus  LP28 strain, which has been deposited as NITE ABP-700 at the National Institute of Technology and Evaluation, Patent Microorganisms Depositary. 
     
     
         6 .  Pediococcus pentosaceus  LP28 strain, which has been deposited as NITE ABP-700 at the National Institute of Technology and Evaluation, Patent Microorganisms Depositary. 
     
     
         7 . Use of cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these, for producing an agent for preventing or ameliorating obesity. 
     
     
         8 . Use of cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these, for producing a fat-accumulation-inhibiting agent. 
     
     
         9 . Use of cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these, for producing a fat-metabolism-improving agent. 
     
     
         10 . A method for preventing or ameliorating obesity, characterized in that the method comprises administering, to a subject in need thereof, cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these, or allowing a subject in need thereof to consume cells of a lactic acid bacterium belonging to the genus  Pediococcus , a cell culture thereof, or an extract of any of these.